ABSTRACT -Background: Studies have shown a high prevalence of migraine among narcoleptic patients. HLA-DQB1*0602 and HLA DRB1 alleles are closely associated with narcolepsy. An increase in the HLA-DRB1 allele frequency in patients with visual aura has raised greater awareness of the genetic background in migraine. Purpose: Since the regions DR and DQ of the HLA are in tightly linkage desiquilibrium we hypothesize that HLA-DQB1*0602 might be associated to the pathophysiology of migraine. Method: We analyzed the presence of HLA DQB1*0602 allele in 50 healthy subjects with no history of migraine, 53 patients with migraine without aura and 52 patients with migraine with aura. Results: There was no difference in the frequency of HLA DQB1*0602 allele when control subjects and all patients were compared. We failed to note any difference in frequencies when comparing migraine patients with and without aura. Conclusion: Further studies with different patient populations, with other hypothalamic markers (melatonin, hypocretin) in migraine patients may shed light on to its pathophysiology.
Migraine is a syndrome characterized by a moderate to severe, throbbing type headache, associated with photophobia, phonophobia, nausea and vomiting. It can be preceded by focal neurological symptoms named aura. It is a common condition, affecting about 6% of men and 20% of women in the general population, with high direct and indirect costs to patients, relatives and society at large 1 . The pathophysiology of migraine has not been fully elucidated. The classical theory described by Moskowitz, which states that migraine is caused by a neuro-vascular infl ammatory reaction modulated by the trigeminal nerve is still accepted [2] [3] [4] . Other aspects including genetics, immune function, and the putative role of the hypothalamus in migraine pathophysiology have been documented [5] [6] [7] . A positive family history is common in migraine, usually found in patients with migraine with aura. An increase of the frequency of HLA-DRB1 allele in patients with visual aura has raised awareness of the genetic background of migraine [8] [9] . The clinical associations of migraine with atopic diseases such as asthma, allergies, and eczemas have high-lighted the immunological background of the syndrome 8 . Recent emphasis has been given to the hypothalamus in headache disorders, particularly those with a close circadian or circannual biology, such as cluster headaches and trigemino-autonomic cephalalgias [9] [10] [11] [12] . But also in migraines 11 . Narcolepsy and migraine may be linked in several ways. Studies have shown a high prevalence of migraine among narcoleptic patients 13 . On the other hand, excessive daytime sleepiness is also found and is apparently not related to sleep apnea 14 
.
The HLA-DQB1*0602 allele is closely associated with narcolepsy 15 . The HLA-DRB1 and DQB1* regions are mapped to the short arm of the chromosome 6 and are in tightly linkage desiquilibrium. They are part of the class II Human Leukocyte Antigen (HLA) complex molecules, these molecules are proteins placed in cell membranes and bind to antigens forming the antigen-antibody complex. The antigen-antibody interaction is the triggering factor for both cell and antibody mediated immune reaction. Any alteration in the structure of these proteins, caused by changes in the sequence of bases of the DNA, can affect the affi nity of the antigen binding thereby modifying the immune response 15 . Genetic polymorphisms are small alterations in the DNA sequence and are widespread in humans. Such alterations may be involved in some diseases as well as phenotypic expression. These modifi cations are also present in the HLA region and some of which are associated with several autoimmune diseases such as systemic lupus erythematosus, rheumatoid arthritis, and systemic sclerosis. Studies have associated HLA alleles with worsing prognosis and evolution of these diseases [16] [17] [18] . Although environmental factors are important in the pathophysiology of these conditions, the increased frequency of the HLA-DQB1*0602 in narcoleptic patients and the high number of narcoleptics with migraine must be considered in order to enhance our understanding of the mechanism of this disease. We hypothesized that HLA-DQB1*0602 might be related to migraine pathophysiology [19] [20] [21] [22] [23] . Mindful of the above, the aim of the present study is to verify the frequency of the HLA-DQB1*0602 allele in migraine patients without sleep diseases.
METHOD
The local ethics committee (UNIFESP-EPM-number /2003) approved the study, all patients and controls gave written consent. Fifty healthy subjects with no history of migraine, fi fty-three patients with migraine and fi fty two patients with migraine with aura participated in this study.
All migraine patients with and without aura fulfi lled the diagnostic criteria according to International Classifi cation of Headache Disorders (IHS) 24 and had more than fi fteen headache episodes per month.
The control group subjects, migraine patients with and without aura were similar regarding age and sex ( Table 1) .
The migraine with aura group was composed by twentysix patients with visual aura (50%), twenty-three (44%) with visual and sensory aura and three (6%) with sensory aura.
Control subjects and patients with personal or familial history of excessive daytime sleepiness according to Epworth Sleepiness Scale (ESS) 25 score of 10 or higher were not included in the present study.
HLA-DQB1*0602 typing -DNA from these individuals was typed for DRB and DQB1 typed by the PCR-Allele Specifi c Amplifi cation (PCR-ASA) method and DQA1 by PCR followed by hybridization using Sequence Specifi c Oligonucleotides (PCR-SSO) 25 . With in at least HLA DQ B1*0602 Allele 11 14 13 (HS X PoA p=0.30), (HS X PwA p=0.39) and (PoA X PwA p=0.86). Chi-square test.
Statistical analysis -The Kolmogorov-Smirnov test was
used to check the homogeneity of variations and t Student test was used for non-matched samples with values presented as mean and standard deviation. Furthermore the chi-square test was used to compare the frequencies of the HLA allele in the several groups studied. Statistical significance was set as p<0.05.
RESULTS
The presence of in at least the DQB1*0602 allele in control subjects was 22% and in patients was 25%, p=0.9. The presence of in at least the DQB1*0602 allele in migraine patients without aura was 25% and in patients with aura was 26%, p=0.9. There was no difference in the frequency of in at least the DQB1*0602 allele when compared control subjects and patients as a whole compared. We found no differences when comparing migraine patients with and without aura ( Table 2) .
DISCUSSION
The present study compared the frequencies of HLA-DQB1*0602 allele in control subjects, migraine patients with and without aura. The frequency of the HLA-DQB1*0602 allele was not difference among the groups studied.
Regarding the pathophysiology it is believed that the neuro anatomical region of the dysfunction in migraine as well as in narcolepsy is probably located in the brain stem [11] [12] [13] . Some neurotransmitters such as serotonin play an important role in the pathophysiology of both disorders. Hypocretins are neuropeptides produced in the lateral hypothalamus with a known role in narcolepsy 24 . Studies have shown that hypocretins interact with pain modulation pathways. A relationship between this neuropeptide with painful syndromes has been reported.
The frequency of HLA-DQB1*0602 allele in narcoleptics demonstrated that low hypocretins levels in cerebrospinal fl uid is as high as 95%. Immunological reactions are thought to be associated with self-destruction of the hypocretin producing cells of the lateral hypothalamus and subsequent hypocretin lower levels in hypocretin [25] [26] [27] . Narcoleptics are more prone to migraine than non-narcoleptics and patients with migraine have experieced worsing pain when changes to sleep time are experieced 8, 28 . The unaltered frequencies of the HLA-DQB1*0602 allele in migraine patients do not exclude a possible pathophysiologic correlation between migraine and narcolepsy. The presence of the HLA-DQB1*0602 allele is only part of complex and unknown pathophysiologic of the narcolepsy. Further studies with different patient populations, with other hypothalamic markers (melatonin, hypocretin) should be important to migraine and narcolepsy in patients and may shed light into pathophysiology.
